Reaction
Infection In An Immunocompromised Host reporting signals
As of the last recalculation, Infection In An Immunocompromised Host appears in 709 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 55.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 23 | 55.7 | 55.8 |
| Valganciclovir | 32 | 52.1 | 52.2 |
| Valganciclovir Hydrochloride | 32 | 52.1 | 52.2 |
| Micafungin Sodium | 11 | 38.7 | 38.7 |
| Ganciclovir | 13 | 38.0 | 38.0 |
| Valganciclovir Hydrochloride Powder, | 15 | 36.9 | 36.9 |
| Mycophenolate Mofetil | 138 | 36.8 | 36.8 |
| Mycophenolate Mofetil Hydrochloride | 138 | 36.7 | 36.8 |
| Ganciclovir Sodium | 13 | 36.7 | 36.8 |
| Voriconazole Injection | 25 | 35.0 | 35.0 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 33.2 | 33.2 |
| Tacrolimus | 139 | 32.2 | 32.2 |
| Voriconazole | 28 | 28.1 | 28.2 |
| Mycophenolic Acid | 29 | 27.7 | 27.7 |
| Mycophenilic Acid | 19 | 27.6 | 27.7 |
| Tacrolimus Ointment 0.1% | 98 | 26.6 | 26.7 |
| Tacrolimus Extended-Release Capsules | 98 | 26.6 | 26.6 |
| Prednisolone | 130 | 25.7 | 25.7 |
| Prednisolone Oral | 130 | 25.7 | 25.7 |
| Prednisolone Oral Solution | 130 | 25.7 | 25.7 |
| Meropenem | 21 | 19.8 | 19.8 |
| Vincristine Sulfate | 17 | 17.4 | 17.4 |
| Cytarabine | 34 | 17.4 | 17.4 |
| Bendamustine Hydrochloride | 7 | 17.3 | 17.3 |
| Selinexor | 5 | 17.1 | 17.1 |
| Bortezomib | 36 | 12.4 | 12.4 |
| Pegaspargase | 5 | 12.1 | 12.1 |
| Blinatumomab | 4 | 11.3 | 11.3 |
| Carfilzomib | 9 | 9.4 | 9.5 |
| Daratumumab | 12 | 9.0 | 9.0 |